These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 5447481)
21. Which drugs should we be testing for bioavailability. Smith RN Br J Clin Pharmacol; 1975 Feb; 2(1):5-7. PubMed ID: 1234487 [No Abstract] [Full Text] [Related]
22. Determining drug equality. Hecht A FDA Consum; 1975 Nov; 9(9):18-20. PubMed ID: 10316633 [No Abstract] [Full Text] [Related]
23. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
24. Views of Louisiana pharmacists on drug product selection. Iyriboz Y; Church G J La State Med Soc; 1986 Nov; 138(11):41-5. PubMed ID: 3794682 [No Abstract] [Full Text] [Related]
33. [Some comments on the International System of Units in pharmacy]. Meulenhoff JS Pharm Weekbl; 1971 Sep; 106(37):698-706. PubMed ID: 5571995 [No Abstract] [Full Text] [Related]
34. Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents? Antman EM; Ferguson JJ Circulation; 2003 Nov; 108(21):2604-7. PubMed ID: 14638523 [No Abstract] [Full Text] [Related]
35. Generic-therapeutic equivalence--enigma or myth? Shirkey HC Hawaii Med J; 1970; 29(3):201-2. PubMed ID: 5416016 [No Abstract] [Full Text] [Related]
36. [Equivalency of drugs and the problem of biological availability]. Hirtz J Rev Prat; 1973 Nov; 23(53):7-10. PubMed ID: 4802222 [No Abstract] [Full Text] [Related]
37. [Modern concept of the drug form]. Lopattin PV Farmatsiia; 1977; 26(6):30-3. PubMed ID: 598523 [No Abstract] [Full Text] [Related]
38. USP standards for dissolution and bioavailability. Grady LT Am J Hosp Pharm; 1982 Sep; 39(9):1546-8. PubMed ID: 7137198 [No Abstract] [Full Text] [Related]